Peter U. Park
Impact in
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 25
- Radiopharmaceutical Chemistry and Applications 4
- Oncology 21
- HER2/EGFR in Cancer Research 17
- CAR-T cell therapy research 5
- Peptidase Inhibition and Analysis 3
- Cancer Treatment and Pharmacology 3
- Co-authors
- Victor S. Goldmacher (4 shared papers)Yulius Y. Setiady (5 shared papers)Jennifer A. Coccia (5 shared papers)Robert J. Lutz (9 shared papers)Hans K. Erickson (3 shared papers)Wayne C. Widdison (1 shared paper)Walter A. Blättler (1 shared paper)Lisa M. Garrett (1 shared paper)
- Journals
- Cancer Research (19 papers)Journal of Natural Products (4 papers)Molecular Cancer Therapeutics (3 papers)Blood (3 papers)Science (2 papers)
- Partner nations
- United StatesGuamFrance
In The Last Decade
Peter U. Park
38 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 104
- Aging 72
- Oncology 687
- Radiology, Nuclear Medicine and Imaging 504
- Hematology 219
- Immunology 334
Countries citing papers authored by Peter U. Park
This map shows the geographic impact of Peter U. Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter U. Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter U. Park more than expected).
Fields of papers citing papers by Peter U. Park
This network shows the impact of papers produced by Peter U. Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter U. Park. The network helps show where Peter U. Park may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter U. Park, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 421 | |
| 2 | 2014 | 245 | |
| 3 | 2009 | 187 | |
| 4 | 2004 | 165 | |
| 5 | 1999 | 125 | |
| 6 | 1995 | 102 | |
| 7 | 2000 | 86 | |
| 8 | 1998 | 76 | |
| 9 | 2013 | 67 | |
| 10 | 2022 | 58 | |
| 11 | 2002 | 47 | |
| 12 | 2022 | 41 | |
| 13 | 1999 | 22 | |
| 14 | 1997 | 21 | |
| 15 | 2022 | 19 | |
| 16 | 1999 | 13 | |
| 17 | 2015 | 12 | |
| 18 | 2011 | 7 | |
| 19 | 2019 | 6 | |
| 20 | 2015 | 6 |
About Peter U. Park
Peter U. Park is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Biotechnology and Immunology, having authored 39 papers that have together received 1.8k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (25 papers), HER2/EGFR in Cancer Research (17 papers), CAR-T cell therapy research (5 papers), Glycosylation and Glycoproteins Research (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Marine Sponges and Natural Products (4 papers), Peptidase Inhibition and Analysis (3 papers) and Cancer Treatment and Pharmacology (3 papers). The work is most often cited by research in Aging (72 citations), Oncology (687 citations), Radiology, Nuclear Medicine and Imaging (504 citations), Hematology (219 citations) and Immunology (334 citations). Peter U. Park has collaborated with scholars based in United States, Guam and France. Frequent co-authors include Victor S. Goldmacher, Yulius Y. Setiady, Jennifer A. Coccia, Robert J. Lutz, Hans K. Erickson, Wayne C. Widdison, Walter A. Blättler, Lisa M. Garrett, Yelena Kovtun and Pierre‐Antoine Defossez. Their work appears in journals such as Cancer Research, Journal of Natural Products, Molecular Cancer Therapeutics, Blood and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.